Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Colonic lymphoid nodular hyperplasia in an adolescent.

Vossenkämper A, Fikree A, Fairclough PD, Aziz Q, MacDonald TT.

J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):684-6. doi: 10.1097/MPG.0b013e318223650a. No abstract available.

PMID:
22134496
2.

Pancolonic spatiotemporal mapping reveals regional deficiencies in, and disorganization of colonic propagating pressure waves in severe constipation.

Dinning PG, Zarate N, Hunt LM, Fuentealba SE, Mohammed SD, Szczesniak MM, Lubowski DZ, Preston SL, Fairclough PD, Lunniss PJ, Scott SM, Cook IJ.

Neurogastroenterol Motil. 2010 Dec;22(12):e340-9. doi: 10.1111/j.1365-2982.2010.01597.x.

PMID:
20879994
3.

Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.

Vossenkämper A, Marchès O, Fairclough PD, Warnes G, Stagg AJ, Lindsay JO, Evans PC, Luong le A, Croft NM, Naik S, Frankel G, MacDonald TT.

J Immunol. 2010 Oct 1;185(7):4118-27. doi: 10.4049/jimmunol.1000500. Epub 2010 Sep 10.

4.

Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines.

Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL, Akker SA, Drake WM, Fairclough PD, Grossman AB, Jenkins PJ.

Eur J Endocrinol. 2010 Jul;163(1):21-8. doi: 10.1530/EJE-09-1080. Epub 2010 Apr 30.

PMID:
20435617
5.

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland.

Gut. 2010 May;59(5):666-89. doi: 10.1136/gut.2009.179804. Review.

PMID:
20427401
6.

Bowel preparation affects the amplitude and spatiotemporal organization of colonic propagating sequences.

Dinning PG, Zarate N, Szczesniak MM, Mohammed SD, Preston SL, Fairclough PD, Lunniss PJ, Cook IJ, Scott SM.

Neurogastroenterol Motil. 2010 Jun;22(6):633-e176. doi: 10.1111/j.1365-2982.2010.01480.x. Epub 2010 Feb 24.

PMID:
20180824
7.

Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.

McLean AM, Fairclough PD.

Best Pract Res Clin Endocrinol Metab. 2005 Jun;19(2):177-93. Review.

PMID:
15763694
8.

Activated STAT4 and a functional role for IL-12 in human Peyer's patches.

Monteleone G, Holloway J, Salvati VM, Pender SL, Fairclough PD, Croft N, MacDonald TT.

J Immunol. 2003 Jan 1;170(1):300-7.

9.

Screening guidelines for colorectal cancer and polyps in patients with acromegaly.

Jenkins PJ, Fairclough PD; British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland.

Gut. 2002 Oct;51 Suppl 5:V13-4. No abstract available.

10.

Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer.

Ogunkolade BW, Boucher BJ, Fairclough PD, Hitman GA, Dorudi S, Jenkins PJ, Bustin SA.

Lancet. 2002 May 25;359(9320):1831-2.

PMID:
12044381
11.

Colorectal neoplasia in acromegaly.

Jenkins PJ, Fairclough PD.

Clin Endocrinol (Oxf). 2001 Dec;55(6):727-9. No abstract available.

PMID:
11895212
12.

Factors associated with tolerance to, and discomfort with, unsedated diagnostic gastroscopy.

Mulcahy HE, Kelly P, Banks MR, Connor P, Patchet SE, Farthing MJ, Fairclough PD, Kumar PJ.

Scand J Gastroenterol. 2001 Dec;36(12):1352-7.

PMID:
11761029
13.

Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.

Miraki-Moud F, Jenkins PJ, Fairclough PD, Jordan S, Bustin SA, Jones AM, Lowe DG, Monson JP, Grossman AB, Besser GM, Camacho-Hübner C.

Clin Endocrinol (Oxf). 2001 Apr;54(4):499-508.

PMID:
11318786
14.

A prospective controlled trial of an ultrathin versus a conventional endoscope in unsedated upper gastrointestinal endoscopy.

Mulcahy HE, Riches A, Kiely M, Farthing MJ, Fairclough PD.

Endoscopy. 2001 Apr;33(4):311-6.

PMID:
11315891
15.

Changing patterns of sedation use for routine out-patient diagnostic gastroscopy between 1989 and 1998.

Mulcahy HE, Hennessy E, Connor P, Rhodes B, Patchett SE, Farthing MJ, Fairclough PD.

Aliment Pharmacol Ther. 2001 Feb;15(2):217-20.

16.

Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile.

Nagata S, McKenzie C, Pender SL, Bajaj-Elliott M, Fairclough PD, Walker-Smith JA, Monteleone G, MacDonald TT.

J Immunol. 2000 Nov 1;165(9):5315-21.

17.

Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Jenkins PJ, Frajese V, Jones AM, Camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM.

J Clin Endocrinol Metab. 2000 Sep;85(9):3218-21.

PMID:
10999811
18.

Dilutional diarrhoea: under-diagnosed and over-investigated.

Pollok RC, Banks MR, Fairclough PD, Farthing MJ.

Eur J Gastroenterol Hepatol. 2000 Jun;12(6):609-11.

PMID:
10912476
19.

Early experience with intrasphincteric botulinum toxin in the treatment of achalasia.

Greaves RR, Mulcahy HE, Patchett SE, Gorard DA, Fairclough PD, Alstead EM, Farthing MJ.

Aliment Pharmacol Ther. 1999 Sep;13(9):1221-5.

20.

Selective COX-2 inhibitors and human inflammatory bowel disease.

McCartney SA, Mitchell JA, Fairclough PD, Farthing MJ, Warner TD.

Aliment Pharmacol Ther. 1999 Aug;13(8):1115-7.

21.
22.

Colorectal neoplasia in acromegaly.

Jenkins PJ, Besser GM, Fairclough PD.

Gut. 1999 May;44(5):585-7. No abstract available.

23.

Ultrathin endoscopy in the assessment and treatment of upper and lower gastrointestinal tract strictures.

Mulcahy HE, Fairclough PD.

Gastrointest Endosc. 1998 Dec;48(6):618-20.

PMID:
9852453
24.

Ultrathin endoscopy and difficult duodenal intubation.

Mulcahy HE, Fairclough PD.

Gastrointest Endosc. 1998 Jul;48(1):115. No abstract available.

PMID:
9684689
25.

General practitioner access to gastroscopy: is 'censorship' valuable?

Mourad FH, Taylor TM, Fairclough PD, Farthing MJ.

Br J Gen Pract. 1998 Apr;48(429):1165-6.

27.

Effective palliation of a colovaginal fistula using a self-expanding metal stent.

Jeyarajah AR, Shepherd JH, Fairclough PD, Patchett SE.

Gastrointest Endosc. 1997 Oct;46(4):367-9. No abstract available.

PMID:
9351046
28.

Acromegaly, colonic polyps and carcinoma.

Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M.

Clin Endocrinol (Oxf). 1997 Jul;47(1):17-22.

PMID:
9302367
29.

A double-blind randomized trial of low-dose versus high-dose topical anaesthesia in unsedated upper gastrointestinal endoscopy.

Mulcahy HE, Greaves RR, Ballinger A, Patchett SE, Riches A, Fairclough PD, Farthing MJ.

Aliment Pharmacol Ther. 1996 Dec;10(6):975-9.

PMID:
8971297
30.

Screening colonoscopy.

Mulcahy HE, Fairclough PD, Farthing MJ.

Lancet. 1996 Sep 28;348(9031):897-8. No abstract available.

PMID:
8826840
31.

Intensity of hemodialysis and response to erythropoietin.

Ballinger AB, Fairclough PD, Clark ML, Farthing MJ.

N Engl J Med. 1996 Jun 20;334(25):1670; author reply 1670-1. No abstract available.

PMID:
8628370
32.

Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report.

Bowling TE, Price AB, al-Adnani M, Fairclough PD, Menzies-Gow N, Silk DB.

Gut. 1996 May;38(5):788-91.

33.

Is intervention necessary after a first episode of acute idiopathic pancreatitis?

Ballinger AB, Barnes E, Alstead EM, Fairclough PD.

Gut. 1996 Feb;38(2):293-5.

34.

Characterisation of penicillin-G uptake in rabbit small-intestinal brush-border membrane vesicles.

Poschet JF, Hammond SM, Fairclough PD.

Biochim Biophys Acta. 1996 Jan 31;1278(2):233-40.

35.

An improved method of handling endoscopic biopsy specimens.

Veitch AM, Fairclough PD.

Gastrointest Endosc. 1995 Feb;41(2):183. No abstract available.

PMID:
7721020
36.

Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.

Catnach SM, Fairclough PD, Hammond SM.

Gut. 1994 Apr;35(4):441-4. Review. No abstract available.

37.

Absorption of a hypotonic oral rehydration solution in a human model of cholera.

Hunt JB, Thillainayagam AV, Carnaby S, Fairclough PD, Clark ML, Farthing MJ.

Gut. 1994 Feb;35(2):211-4.

38.

Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.

Catnach SM, Ballinger AB, Stevens M, Fairclough PD, Trembath RC, Drury PL, Watkins PJ.

Gut. 1993 Aug;34(8):1123-7.

39.

Gall stones and gall bladder motility.

O'Donnell LJ, Fairclough PD.

Gut. 1993 Apr;34(4):440-3. Review. No abstract available.

40.

Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man.

Catnach SM, Ballinger AB, Law PA, Nellans H, Fairclough PD.

Aliment Pharmacol Ther. 1993 Feb;7(1):55-9.

PMID:
8439638
41.

Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.

Catnach SM, Anderson JV, Fairclough PD, Trembath RC, Wilson PA, Parker E, Besser GM, Wass JA.

Gut. 1993 Feb;34(2):270-3.

42.

A new model of human secretory diarrhoea using cholera toxin.

Hunt JB, Thillainayagam AV, Carnaby S, Fairclough PD, Clark ML, Farthing MJ.

Aliment Pharmacol Ther. 1992 Oct;6(5):619-27.

PMID:
1330019
43.

Prevalence of gastritis in patients with acromegaly: untreated and during treatment with octreotide.

Anderson JV, Catnach S, Lowe DG, Fairclough PD, Besser GM, Wass JA.

Clin Endocrinol (Oxf). 1992 Sep;37(3):227-32.

PMID:
1424205
44.

Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones.

Catnach SM, Fairclough PD, Trembath RC, O'Donnell LJ, McLean AM, Law PA, Wickham JE.

Gastroenterology. 1992 Jun;102(6):2071-6.

PMID:
1587426
45.

Water and solute absorption from hypotonic glucose-electrolyte solutions in human jejunum.

Hunt JB, Elliott EJ, Fairclough PD, Clark ML, Farthing MJ.

Gut. 1992 Apr;33(4):479-83.

46.

Biliary stents.

Catnach SM, Fairclough PD.

Br J Hosp Med. 1992 Mar 18-31;47(6):420-5. Review.

PMID:
1568082
47.

Erythromycin and the gut.

Catnach SM, Fairclough PD.

Gut. 1992 Mar;33(3):397-401. Review.

48.

Patient referral and NHS reforms.

Fairclough PD.

Lancet. 1992 Feb 22;339(8791):498-9. No abstract available.

PMID:
1346855
49.

Indomethacin and postprandial gallbladder emptying.

O'Donnell LJ, Wilson P, Guest P, Catnach SM, McLean A, Wickham JE, Fairclough PD.

Lancet. 1992 Feb 1;339(8788):269-71.

PMID:
1346283
50.

Gastrointestinal involvement in Wegener's granulomatosis.

Pinkney JH, Clarke G, Fairclough PD.

Gastrointest Endosc. 1991 May-Jun;37(3):411-2. No abstract available.

PMID:
2071011

Supplemental Content

Loading ...
Support Center